Seeking NY Patients on Medication for Opioid Use Disorder Who Need Admission to a Long-Term Care Facility
The Legal Action Center and Disability Rights Advocates are investigating discrimination by nursing homes or other long-term care facilities in NYC and NYS, against people receiving medication for opioid use disorder (MOUD).
MOUD is the use of methadone, buprenorphine (often goes by the brand name Suboxone), or injectable naltrexone (Vivitrol) to treat opioid use disorder. People who receive MOUD may need continuing medical treatment in a long-term care facility for an array of medical issues. However, these facilities often deny them admission because they receive MOUD.
We want to hear from people receiving MOUD who may have experienced any of the following in NYC or NYS:
- You have been denied admission to a long-term care facility;
- Your hospital has been unable to find a place for you at a longterm care facility; or
- You are receiving MOUD and would like to be treated in a longterm care facility.
We want to hear from you!
Contact the Legal Action Center at (212) 243-1313 or by email at email@example.com.
Please share this information with anyone who was excluded – or knows people who were excluded – from a long-term care facility due to their treatment with MOUD.